Thursday, September 04, 2014 3:18:36 PM
Graphene 3D Lab is a Calverton, N.Y. based company that began trading in Canada initially, with a U.S. listing pending.
The company is likely to be the first to market with graphene filaments for 3D printing.
Web site: http://www.graphene3dlab.com/s/home.asp
Gary Anderson wrote a great article and introduction to this company.
https://3dprintingstocks.com/best-3d-printing-stock-ggg/
Graphene 3D Lab Inc. Files Provisional Patent Application Related to 3D Printable Batteries
http://www.marketwatch.com/story/graphene-3d-lab-inc-files-provisional-patent-application-related-to-3d-printable-batteries-2014-09-02
http://graphenelab.com/pdf/PressRelease-Sept2-2014.pdf
More links regarding the battery demo
http://www.engineering.com/3DPrinting/3DPrintingArticles/ArticleID/8404/Graphene-3D-Lab-GGGV-to-Demo-3D-Printed-Batteries.aspx
https://3dprintingstocks.com/graphene-3d-lab-ggg-v/
http://3dprint.com/13788/3d-printed-graphene-batteries/
Things to look forward to:
graphene filaments availability within 6mos (need date)
Demo of 3D printed batteries (need date)
US stock listing within next few months (need date)
As always...do your own due diligence before making an investment decision.
Recent GGG News
- Graco Reports First Quarter Results • Business Wire • 04/24/2024 08:10:00 PM
- Graco Inc. Announces First Quarter 2024 Earnings Conference Call • Business Wire • 04/08/2024 02:00:00 PM
- Graco Launches TruMix XT™ Variable-Ratio Mixing System • Business Wire • 04/03/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:19:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:18:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 06:36:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 06:04:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 06:25:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 10:06:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 07:27:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 07:22:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 07:35:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 03:42:53 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/20/2024 05:52:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 01:31:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 01:29:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 01:28:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 01:27:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 01:25:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 01:24:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 01:22:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 01:21:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 01:13:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 01:11:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 01:10:21 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM